AgomAb Therapeutics
Natalie De Jonge has a diverse work experience starting from their role as a Postdoctoral Researcher at Vrije Universiteit Brussel in 2009. Natalie then worked at argenx, where they held roles as a Scientist, Senior Scientist, PM, CSM, and finally as a Regulatory Affairs Manager from 2017 to 2022. In 2022, they joined Copact Coaching bvba as a Beleidsmedewerker for a short period. Currently, they are working as a Regulatory Affairs Manager at Agomab Therapeutics since February 2023.
Natalie De Jonge attended Vrije Universiteit Brussel from 1999 to 2004, earning a Master's degree in Bio-engineering.
This person is not in any offices
AgomAb Therapeutics
AgomAb is pioneering therapies that modulate regenerative pathways to achieve structural tissue repair and functional organ recovery.